Developing Aptamers by Cell-Based SELEX.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Methods in molecular biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-1-4939-3197-2_3PMID 26552814
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multifunctional aptamer-miRNA conjugates for targeted cancer therapy.

  2014cited by this paper
• Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers

  2012cited by this paper
• Targeting Axl with an high-affinity inhibitory aptamer.

  2012cited by this paper
• Rapid Identification of Cell-Specific, Internalizing RNA Aptamers with Bioinformatics Analyses of a Cell-Based Aptamer Selection

  2012cited by this paper
• A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death

  2011cited by this paper
• Targeting cancer cells with nucleic acid aptamers.

  2010cited by this paper
• Directed evolution of gold nanoparticle delivery to cells.

  2010cited by this paper
• DNA Aptamers as Molecular Probes for Colorectal Cancer Study

  2010cited by this paper
• Aptamers as therapeutics

  2010cited by this paper
• Differential SELEX in Human Glioma Cell Lines

  2009cited by this paper
• Aptamers as inhibitors of target proteins

  2009cited by this paper
• CS-SELEX Generates High-Affinity ssDNA Aptamers as Molecular Probes for Hepatitis C Virus Envelope Glycoprotein E2

  2009cited by this paper
• Invited Article: The expanding impact of molecular biology on the diagnosis and treatment of gliomas

  2008cited by this paper
• Molecular Recognition of Small‐Cell Lung Cancer Cells Using Aptamers

  2008cited by this paper
• Malignant gliomas in adults.

  2008cited by this paper
• Designer Therapies for Glioblastoma Multiforme

  2008cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• DNA Aptamers That Bind to MUC1 Tumour Marker: Design and Characterization of MUC1-Binding Single-Stranded DNA Aptamers

  2006cited by this paper
• Aptamers evolved from live cells as effective molecular probes for cancer study

  2006cited by this paper
• Molecular pathology of malignant gliomas.

  2006cited by this paper
• Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface.

  2006cited by this paper
• Inhibition of heregulin signaling by an aptamer that preferentially binds to the oligomeric form of human epidermal growth factor receptor-3

  2003cited by this paper
• Genetic and signaling pathway alterations in glioblastoma: relevance to novel targeted therapies.

  2003cited by this paper
• Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.

  2002cited by this paper

• Targeting Glioblastoma Stem Cells via EphA2: Structural Insights into the RNA Aptamer A40s for Precision Therapy

  2025cites this paper
• Precision Oncology: Advances in Drug Delivery and Imaging.

  2024cites this paper
• Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer.

  2021cites this paper
• Optimization of RNA Aptamer SELEX Methods: Improved Aptamer Transcript 3′-End Homogeneity, PAGE Purification Yield, and Target-Bound Aptamer RNA Recovery

  2021cites this paper
• Advances in Oligonucleotide Aptamers for NSCLC Targeting

  2020cites this paper
• Targeted systematic evolution of an RNA platform neutralizing DNMT1 function and controlling DNA methylation

  2020cites this paper
• An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery

  2019cites this paper
• Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes

  2019cites this paper
• The Discovery of RNA Aptamers that Selectively Bind Glioblastoma Stem Cells

  2019cites this paper
• Nucleic Acid Aptamers Targeting Epigenetic Regulators: An Innovative Therapeutic Option

  2018cites this paper
• A biolayer interferometry-based enzyme-linked aptamer sorbent assay for real-time and highly sensitive detection of PDGF-BB.

  2018cites this paper
• Aptamer‐guided nanomedicines for anticancer drug delivery

  2018cites this paper
• [Screening of nucleic acid aptamer of lung cancer cells based on cell exponential enrichment ligand system evolution and its application in tumor diagnosis and treatment].

  2018cites this paper
• Nanopore based detection of Bacillus thuringiensis HD-73 spores using aptamers and versatile DNA hairpins.

  2018cites this paper
• Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma

  2017cites this paper
• Innovative therapeutic tools to prevent BM-MSC recruitment and activity into tumor microenvironment

  2016cites this paper
• Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL

  2016cites this paper
• Targeting Insulin Receptor with a Novel Internalizing Aptamer

  2016cites this paper
• IN – INSTITUTE OF NEUROSCIENCE

  2016cites this paper
• Aptamers in hematological malignancies and their potential therapeutic implications.

  2016cites this paper
• IN – INSTITUTE OF NEUROSCIENCE

  2016cites this paper